How can we shift from conventional to collaborative therapy with all HF drugs?
dr. Hawani Sasmaya SpJP(K)
Skip to PDF content
Ina HF Carmet
Indonesian Heart Failure and Cardiometabolic Disease Working Group
How can we shift from conventional to collaborative therapy with all HF drugs?